Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats
about
An experimental approach to study the function of mitochondria in cardiomyopathyTransition metals and mitochondrial metabolism in the heartA Biophysical Systems Approach to Identifying the Pathways of Acute and Chronic Doxorubicin Mitochondrial CardiotoxicityHydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truthCardiomyocyte death in doxorubicin-induced cardiotoxicityIn utero exposure of female CD-1 Mice to AZT and/or 3TC: I. Persistence of microscopic lesions in cardiac tissue.P53 inhibition exacerbates late-stage anthracycline cardiotoxicity.Advances in iron chelation: an update.Anthracycline-containing chemotherapy causes long-term impairment of mitochondrial respiration and increased reactive oxygen species release in skeletal muscle.High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia.Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin.Saffron extracts alleviate cardiomyocytes injury induced by doxorubicin and ischemia-reperfusion in vitro.Apoptosis in Anthracycline CardiomyopathyQuantifying Drug-Induced Nanomechanics and Mechanical Effects to Single Cardiomyocytes for Optimal Drug Administration To Minimize Cardiotoxicity.Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study.Drug-induced mitochondrial dysfunction and cardiotoxicity.Different effects of resveratrol on dose-related Doxorubicin-induced heart and liver toxicity.Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection.Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors.Inauhzin sensitizes p53-dependent cytotoxicity and tumor suppression of chemotherapeutic agents.Doxorubicin induced heart failure: Phenotype and molecular mechanisms.Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric OncologAssessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trialDoxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-QMechanisms and management of doxorubicin cardiotoxicity.Beet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells.Mechanisms of Cardiomyocyte Proliferation and Differentiation in Development and Regeneration.Chironomus riparius exposure to fullerene-contaminated sediment results in oxidative stress and may impact life cycle parameters.Grape seed and skin extract protects against arsenic trioxide induced oxidative stress in rat heart.Prevention and treatment of doxorubicin-induced cardiotoxicity by dexrazoxane and schisandrin B in rabbits.Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cells.Effects of molsidomine against doxorubicin-induced cardiotoxicity in rats.Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat model.Naphthoquinones: A continuing source for discovery of therapeutic antineoplastic agents.Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle function.A-Kinase Anchoring Protein-Lbc: A Molecular Scaffold Involved in Cardiac Protection.Effects of age on multidrug resistance protein expression and doxorubicin accumulation in cardiac and skeletal muscle.The impact of doxorubicin and dexrazoxane injection of prepubertal female rats on pregnancy outcome and cardiac function postpartum.Cardiac response to doxorubicin and dexrazoxane in intact and ovariectomized young female rats at rest and after swim training.Effects of histidine and N-acetylcysteine on doxorubicin-induced cardiomyopathy in rats.
P2860
Q26801342-380FF44E-C0A2-48E8-A17E-FA7FAEF373EFQ26999334-CD2D1AAB-BEBF-4B10-AE88-B5CE8D0FA519Q28553631-A32C9245-D9A9-4ABC-91A1-C43C8B8B5BA3Q30457642-63FE9ABC-109E-46A2-BFBF-CA217FA7235CQ33604134-FC7C4D09-7307-4A27-94C2-BEC1C5EC2236Q33839401-EEAD5A67-30DA-4C8A-8BFD-7297F80CCA11Q34048273-7753734F-4DD7-44AA-8C4F-496D874B2FD5Q34174307-64D3F4B0-C485-43D7-9000-BDE5174B23AFQ35138773-AA8D7B4C-F827-4304-A738-1DB2BF692852Q35216069-485D3F79-8498-4F7B-8E97-7FA7B0BD0680Q35550223-3747F45A-B349-4319-97E1-167443ECB388Q35606032-56C36C56-F7A8-41B5-B0AD-4FD461D8D200Q35642302-2288B8AC-2CDD-4451-B2EC-B457F4AB7074Q35887269-DCD623EA-BB1C-4AE4-9F4D-E84816025736Q36245459-CC82CF37-1F1F-4CD6-AF90-B7C6FFF85309Q36339445-13CD73AF-9779-481F-8842-9DAA51C7A938Q36467387-B218B034-5112-4D2D-A75F-7FE63245420CQ36568908-B26D83F8-B7B1-4956-BF4F-78DA94315B5EQ36649653-787323B1-090E-4288-8B59-35C9AC36CC10Q36801098-375A2E71-CA56-4013-B3C9-3FC189403394Q36912561-3B53A715-DF14-465D-B821-1F33DE086D85Q36914391-200D4582-C942-4F41-AEE3-D498321466A8Q37129069-FE85C21B-9137-476B-A673-6E4EFA92F9E8Q37279228-FD2D5344-47CC-459D-A3CC-816763D82ECDQ38473474-1D411960-2952-4F5C-BCED-9E04AA57F22AQ38749854-EE4E15DA-2FA7-4E04-8047-FBA1A51F9939Q39129349-F57119DF-58F5-4E83-B887-04F610871F69Q39766871-A8C70822-890A-49F9-99FE-75402BFE981FQ40330350-5CCB5416-6488-48E0-9C7B-9BB37BA15BA1Q42726091-055C6E3B-2727-442F-AE5A-134E22AE8173Q43495742-33652401-E34F-4D91-961F-1D46D2A61F1AQ44633014-1DAA257B-7434-41E2-B357-58E703638B4EQ46171847-7AF93DC9-5A21-4BB7-8DEB-B4922064D8ECQ46262914-EA4586AD-BABE-4A4D-9B00-E1763BF58A08Q47266736-6507396A-FC6C-4023-803B-F49A9188F043Q50117582-6DA9CE51-B4A7-4B7D-BAF0-A092C00CFD01Q51192184-12D9AEF0-F86D-4B6A-B7E5-3DB8EC276642Q51294069-3891F675-8186-4782-840D-345DB253198BQ51350978-CBCF9275-EDF4-48A8-8FF0-EF79DE6CFB91Q54390048-D998B7B8-B063-473D-946F-92D0D48F2153
P2860
Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Dexrazoxane prevents doxorubic ...... and functional lesions in rats
@ast
Dexrazoxane prevents doxorubic ...... and functional lesions in rats
@en
type
label
Dexrazoxane prevents doxorubic ...... and functional lesions in rats
@ast
Dexrazoxane prevents doxorubic ...... and functional lesions in rats
@en
prefLabel
Dexrazoxane prevents doxorubic ...... and functional lesions in rats
@ast
Dexrazoxane prevents doxorubic ...... and functional lesions in rats
@en
P2093
P2860
P356
P1476
Dexrazoxane prevents doxorubic ...... and functional lesions in rats
@en
P2093
D Lebrecht
J Haberstroh
U A Walker
U-P Ketelsen
P2860
P304
P356
10.1038/SJ.BJP.0707294
P407
P577
2007-05-21T00:00:00Z